Advanced search
Publication Cover
Clinical and Experimental Hypertension Volume 45, 2023 - Issue 1
Submit an article Journal homepage
3,052
Views
2
CrossRef citations to date
0
Altmetric
Research Article

GSDMD-mediated pyroptosis promotes cardiac remodeling in pressure overload

Jieyun Youa Department of Cardiovascular Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, ChinaView further author information
,
Xuan Lib Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, ChinaView further author information
,
Fangjie Daib Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, ChinaView further author information
,
Jun Liua Department of Cardiovascular Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, ChinaView further author information
,
Qi Zhanga Department of Cardiovascular Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, ChinaCorrespondence[email protected]
View further author information
&
Wei Guoa Department of Cardiovascular Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, ChinaCorrespondence[email protected]
View further author information
Article: 2189138 | Received 05 Sep 2022, Accepted 04 Mar 2023, Published online: 12 Mar 2023

References

  • You J, Wu J, Zhang Q, Ye Y, Wang S, Huang J, Liu H, Wang X, Zhang W, Bu L, et al. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload. Am J Physiol Heart Circ Physiol. 2018;314:H552–7. doi:10.1152/ajpheart.00212.2017.
  • Shi H, Gao Y, Dong Z, Yang J, Gao R, Li X, Zhang S, Ma L, Sun X, Wang Z, et al. GSDMD-Mediated cardiomyocyte pyroptosis promotes myocardial I/R injury. Circ Res. 2021; 129(3):383–96. doi:10.1161/CIRCRESAHA.120.318629
  • Wang Y, Liu X, Shi H, Yu Y, Yu Y, Li M, Chen R. NLRP3 inflammasome, an immune-inflammatory target in pathogenesis and treatment of cardiovascular diseases. Clin Transl Med. 2020; 10(1):91–106. doi:10.1002/ctm2.13
  • Xu B, Jiang M, Chu Y, Wang W, Chen D, Li X, Zhang Z, Zhang D, Fan D, Nie Y, et al. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. J Hepatol. 2018; 68(4):773–82. doi:10.1016/j.jhep.2017.11.040
  • Evavold CL, Kagan JC. Defying death: the (w)hole truth about the fate of GSDMD pores. Immunity. 2019; 50(1):15–17. doi:10.1016/j.immuni.2018.12.032
  • Suetomi T, Willeford A, Brand CS, Cho Y, Ross RS, Miyamoto S, Brown JH. Inflammation and NLRP3 inflammasome activation initiated in response to pressure overload by Ca 2+/calmodulin-dependent protein kinase II δ signaling in cardiomyocytes are essential for adverse cardiac remodeling. Circulation. 2018; 138(22):2530–44. doi:10.1161/CIRCULATIONAHA.118.034621
  • Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015; 526(7575):660–65. doi:10.1038/nature15514
  • Rühl S, Shkarina K, Demarco B, Heilig R, Santos JC, Broz P. ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. Science. 2018; 362(6417):956–60. doi:10.1126/science.aar7607
  • Xia S, Hollingsworth LR, Wu H. Mechanism and regulation of gasdermin-mediated cell death. Cold Spring Harb Perspect Biol. 2020; 12(3):a036400. doi:10.1101/cshperspect.a036400
  • Hu JJ, Liu X, Xia S, Zhang Z, Zhang Y, Zhao J, Ruan J, Luo X, Lou X, Bai Y, et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol. 2020; 21(7):736–45. doi:10.1038/s41590-020-0669-6
  • You J, Wu J, Jiang G, Guo J, Wang S, Li L, Ge J, Zou Y. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice. J Cardiovasc Pharmacol. 2013; 61(2):142–51. doi:10.1097/FJC.0b013e31827a0278
  • Li X, Dai F, Wang H, Wei G, Jiang Q, Yin P, Wang S, Ge J, Yang C, Wu J, et al. PCSK9 participates in oxidized-low density lipoprotein-induced myocardial injury through mitochondrial oxidative stress and Drp1-mediated mitochondrial fission. Clin Transl Med. 2022; 12(2):e729. doi:10.1002/ctm2.729
  • Han J, Dai S, Zhong L, Shi X, Fan X, Zhong X, Lin W, Su L, Lin S, Han B, et al. GSDMD (Gasdermin D) mediates pathological cardiac hypertrophy and generates a feed-forward amplification cascade via mitochondria-STING (stimulator of interferon genes) axis. Hypertension. 2022; 79(11):2505–18. doi:10.1161/HYPERTENSIONAHA.122.20004

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.